There is an ongoing discussion on the risk-benefit-ratio of hormonal r
eplacement therapy (HRT). Potential risks of oestrogen replacement inc
lude the progression of malignant tumours. However postmenopausal morb
idity can be significantly reduced by HRT. There is increasing evidenc
e that oestrogens exercise protective effects on the cardiovascular sy
stem. HRT can reduce the development of atherosclerotic lesions and th
e rate of fatal myocardial infarction due to atherosclerosis. Oestroge
ns have direct and indirect effects on vascular physiology. Indirect e
ffects derive from modulation of lipid metabolism. In addition, oestro
gens may exert direct effects on vascular cells e.g. endothelial and s
mooth muscle cells by receptor-mediated mechanisms (so called genomic
effects) and receptor-independent actions (=non-genomic effects). Espe
cially these non-genomic oestrogen effects have been attracting much a
ttention during recent years.